Vol 5, No 4 (August 29, 2016): Translational Lung Cancer Research

Review Article

From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel
Chunxia Su, Mathias Meyer, Robert Pirker, Wieland Voigt, Jingyun Shi, Lothar Pilz, Rudolf M. Huber, Yilong Wu, Jinghong Wang, Yonglan He, Xuan Wang, Jian Zhang, Xiuyi Zhi, Meiqi Shi, Bo Zhu, Stefan S. Schoenberg, Thomas Henzler, Christian Manegold, Caicun Zhou, Eric Dominic Roessner
Targeting angiogenesis in small cell lung cancer
Michalis Stratigos, Alexios Matikas, Alexandra Voutsina, Dimitrios Mavroudis, Vassilis Georgoulias
Histopathological transformation to small-cell lung carcinoma in non-small-cell lung carcinoma tumors
Rita Dorantes-Heredia, José Manuel Ruiz-Morales, Fernando Cano-García

Original Article

S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer
Humberto Choi, Vikram Puvenna, Chanda Brennan, Shamseldeen Mahmoud, Xiao-Feng Wang, Michael Phillips, Damir Janigro, Peter Mazzone

Evidence-Based Medicine2

Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis
Jiajia Jin, Ping Zhan, Hong Qian, Xiaoxia Wang, Masaru Katoh, Kevin Phan, Jin-Haeng Chung, Tangfeng Lv, Yong Song, Written on behalf of the AME Lung Cancer Collaborative Group

Perspective

Integrative physicians and an herbal cancer “cure”
Eran Ben-Arye, Shoshana Keren Rosenberg, Noah Samuels

Disclosure:

1. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.

2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.